Key Takeaways
- • Sacramento County Employees' Retirement System (SCERS) committed $35 million to OrbiMed Private Investments X, a venture capital fund managed by OrbiMed Advisors, expanding its alternative investment exposure in the healthcare and life sciences sector.
- • SCERS terminated its relationship with Lazard Asset Management, which managed a $379 million international equity mandate, signaling a strategic reallocation away from traditional international developed markets equities.
- • The $35 million venture capital commitment aligns with SCERS's broader 2024 strategy to deploy approximately $250 million in private equity commitments, demonstrating an institutional shift toward higher-return alternative assets.
- • The termination of Lazard's $379 million mandate represents a significant manager transition, likely reflecting performance concerns or strategic portfolio rebalancing within SCERS's international equity allocation.
Summary
Sacramento County Employees' Retirement System has committed $35 million to OrbiMed Private Investments X, a venture capital fund focused on healthcare and life sciences investments managed by OrbiMed Advisors. This deployment represents part of a larger strategic initiative to increase alternative asset exposure within the public pension fund's portfolio.
Concurrent with this venture capital commitment, SCERS terminated its relationship with Lazard Asset Management, which had managed a $379 million international equity portfolio on behalf of the fund. The termination signals a material shift in SCERS's asset allocation strategy, moving capital away from traditional international developed markets equities toward higher-growth, alternative investment vehicles. This decision reflects broader industry trends among institutional investors seeking enhanced returns through private markets exposure.
The $35 million OrbiMed commitment fits within SCERS's stated 2024 objective to target approximately $250 million in total private equity commitments throughout the year. This disciplined capital deployment strategy demonstrates the fund's structured approach to building exposure to venture capital and private equity while managing liquidity and diversification requirements. The commitment to OrbiMed, a specialized healthcare investment manager, provides SCERS with focused exposure to the life sciences and healthcare innovation sectors, which have historically offered attractive return profiles for sophisticated institutional investors.
The termination of Lazard's mandate and concurrent reallocation suggest SCERS is recalibrating its international equity strategy, potentially consolidating managers or shifting toward more concentrated mandates. These portfolio decisions reflect the ongoing evolution of public pension fund investment strategies as fiduciaries balance traditional equity exposure with alternative asset allocations to meet long-term liability obligations in a challenging return environment.
Concurrent with this venture capital commitment, SCERS terminated its relationship with Lazard Asset Management, which had managed a $379 million international equity portfolio on behalf of the fund. The termination signals a material shift in SCERS's asset allocation strategy, moving capital away from traditional international developed markets equities toward higher-growth, alternative investment vehicles. This decision reflects broader industry trends among institutional investors seeking enhanced returns through private markets exposure.
The $35 million OrbiMed commitment fits within SCERS's stated 2024 objective to target approximately $250 million in total private equity commitments throughout the year. This disciplined capital deployment strategy demonstrates the fund's structured approach to building exposure to venture capital and private equity while managing liquidity and diversification requirements. The commitment to OrbiMed, a specialized healthcare investment manager, provides SCERS with focused exposure to the life sciences and healthcare innovation sectors, which have historically offered attractive return profiles for sophisticated institutional investors.
The termination of Lazard's mandate and concurrent reallocation suggest SCERS is recalibrating its international equity strategy, potentially consolidating managers or shifting toward more concentrated mandates. These portfolio decisions reflect the ongoing evolution of public pension fund investment strategies as fiduciaries balance traditional equity exposure with alternative asset allocations to meet long-term liability obligations in a challenging return environment.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.